Search Results 61-70 of 24412 for Lateral

  1. Experimental Antisense Oligonucleotide Treatment for Amyotrophic Lateral Sclerosis With an arg15leu Pathogenic Variant in CHCHD10. - Mayo Clinic

    Experimental Antisense Oligonucleotide Treatment for Amyotrophic Lateral Sclerosis With an arg15leu Pathogenic Variant in CHCHD10. · Overview · Participation ...

  2. Pridopidine in Amyotrophic Lateral Sclerosis (EAP 2) - Mayo Clinic

    The purpose of this study is to provide access to the investigational product, pridopidine, for up to 200 participants with ALS who are ineligible for clinical ...

  3. Doctors and departments - Mayo Clinic

    Amyotrophic lateral sclerosis (ALS). Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with ...

  4. Radicava® (Edaravone) Biomarker Study In Participants With Amyotrophic Lateral Sclerosis - Mayo Clinic

    Radicava® (Edaravone) Biomarker Study In Participants With Amyotrophic Lateral Sclerosis · Overview · Participation eligibility · Participating Mayo Clinic ...

  5. Focus Areas - Neuroscience - Mayo Clinic Research

    ... lateral sclerosis and ataxias. Through basic, translational and clinical research, investigators focus on determining the molecular causes of these diseases ...

  6. Peripheral neuropathy - Doctors and departments - Mayo Clinic

    ... lateral sclerosis, Muscle weakness, Polymyositis, Dermatomyositis, Scapuloperoneal muscular dystrophy, Juvenile motor neuron disease, Juvenile amyotrophic ...

  7. A Study Of New Outcome Measures To Assess The Progression Of Amyotrophic Lateral Sclerosis - Mayo Clinic

    The purpose of this study is to evaluate and rank-order a set of new outcome measures administered to patients with amyotrophic lateral sclerosis (ALS), in ...

  8. Projects - Neuropathology and Microscopy Lab: Dennis W. Dickson - Mayo Clinic Research

    Amyotrophic lateral sclerosis (ALS) and frontotemporal degeneration with TDP-43 pathology · Einstein Aging Study · Disorders in tau pathology · Genetic studies.

  9. An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS) (VALOR (Part C)) - Mayo Clinic

    An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS) (VALOR ( ...

  10. Neurology - Doctors - Mayo Clinic

    Areas of focus: Primary lateral sclerosis, Muscular dystrophy, Myasthenia gravis, Amyotrophic lateral sclerosis, Mitochondrial disease,... Motor neuron ...